GEODE CAPITAL MANAGEMENT, LLC
Position in TLSI — TriSalus Life Sciences, Inc.
CIK 1214717
BOSTON, MA
Position in TLSI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,414,804
+$2,306,428 QoQ
Shares Held
1,190,067
+53.1% QoQ
Ownership
1.93%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 83 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLSI Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,510,306,841 across 125 Medical Devices names. TLSI ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
39,219,337 | $3,558,762,638 | |
| 2 | SYK |
Stryker Corp
|
7,819,802 | $2,461,986,461 | |
| 3 | MDT |
Medtronic plc
|
30,192,015 | $2,361,921,333 | |
| 4 | BSX |
Boston Scientific Corp
|
33,440,102 | $1,427,223,552 | |
| 5 | EW |
Edwards Lifesciences Corp
|
15,437,251 | $1,396,453,724 | |
| 6 | DXCM |
Dexcom Inc
|
12,426,515 | $836,925,784 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
12,871,800 | $823,923,917 | |
| 8 | STE |
STERIS plc
|
2,615,842 | $550,817,849 |
All Filings in TLSI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,414,804 | 1,190,067 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,108,376 | 777,094 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,243,424 | 751,207 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,578,214 | 554,455 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,480,027 | 455,051 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,211,219 | 219,424 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,022,726 | 204,137 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $923,967 | 200,427 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $761,125 | 137,885 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,307,465 | 134,099 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,062,688 | 125,762 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $88,263 | 17,239 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 MTAC | — | 17,239 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 MTAC | — | 17,239 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 MTAC | — | 17,239 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 MTAC | — | 17,239 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 MTAC | — | 17,239 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 MTAC | — | 17,239 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 MTAC | — | 18,606 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 MTAC | — | 18,606 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 MTAC | — | 18,606 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 MTAC | — | 17,265 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||